LP-300

Drug identity checked against registry records

Also recorded as BNP7787; Dimesna; Tavocept

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung AdenocarcinomaNCT05456256LTRNPhase 2Recruiting2026-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.